In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...
Alvotech and Teva Pharmaceuticals have announced the FDA's acceptance of their Biologics ... Alvotech disclaims responsibility for the content of periodic filings, disclosures and other reports ...
The Shiromani Akali Dal (SAD) parliamentary board on Thursday closed the process of distribution of membership copies for the recruitment of new members and informed that 33 lakh forms had been ...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN CANADA, AUSTRALIA, NEW ZEALAND, SOUTH AFRICA, JAPAN, HONG KONG, SOUTH KOREA, OR ANY ...
Prime Minister Narendra Modi and Amir of Qatar Sheikh Tamim Bin Hamad Al-Thani on Tuesday unequivocally condemned terrorism in all its forms and manifestations, including cross-border terrorism, as ...
As a consequence of the extension of the acceptance period, the settlement of the Offer will be postponed correspondingly. The Offeror maintains its right to further extend the acceptance period for ...
Bitcoin (BTC) continued its downward trend on Tuesday as K33 Research's weekly report indicated growing declines in BTC CME ...
A K33 report highlights volumes, yields, options premiums, and ETF flows have moved to areas not seen since before the US ...
Rewinding to 2009, when MTN launched Mobile Money, setting the tone for a digital revolution in Ghana that changed the ...
Closing the oversubscribed brokered offering for $5.75 million of gross proceeds. Participation by all directors and officers of the Company, maintaining alignment to ...
Below is the text of Gov. J.B. Pritzker's State of the State and Budget Address. *Remarks as Prepared for Delivery* Speaker ...
WINNIPEG, MB / ACCESS Newswire / February 18, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals ...